The RIMKLB antibody is a research tool designed to target the RIMK-like family member B (RIMKLB), a protein encoded by the *RIMKLB* gene in humans. RIMKLB belongs to the RIMK family, which includes proteins involved in metabolic processes such as the post-translational modification of ribosomal proteins. Specifically, RIMKLB is implicated in the beta-alanine biosynthesis pathway, catalyzing the ATP-dependent phosphorylation of ribosome-associated proteins, though its exact biological roles remain under investigation. The antibody is commonly used in molecular biology and biochemical studies to detect and quantify RIMKLB expression in tissues or cell lines, aiding in research on its function and regulation. Its applications span Western blotting, immunohistochemistry, and immunofluorescence, helping to elucidate RIMKLB's localization and interaction networks. Dysregulation of RIMKLB has been tentatively linked to metabolic disorders and neurological conditions, though conclusive evidence is still emerging. Researchers utilize this antibody to explore its potential roles in cellular metabolism, ribosomal function, and disease mechanisms, contributing to broader studies on amino acid metabolism and protein synthesis pathways. Commercial RIMKLB antibodies are typically developed in host species like rabbits or mice, validated for specificity and sensitivity in experimental models.